Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)

de Heuvel, Erik, Singh, Abhimanyu K., Boronat, Pierre, Kooistra, Albert J., van der Meer, Tiffany, Sadek, Payman, Blaazer, Antoni R., Shaner, Nathan C., Bindels, Daphne S., Caljon, Guy, and others. (2019) Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2). Bioorganic & Medicinal Chemistry, 27 (18). pp. 4013-4029. ISSN 0968-0896. (doi:10.1016/j.bmc.2019.06.026) (KAR id:76976)

PDF Publisher pdf Language: English This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Download this file (PDF/6MB)	Preview
Request a format suitable for use with assistive technology e.g. a screenreader
Official URL: https://doi.org/10.1016/j.bmc.2019.06.026

Abstract

Inhibitors against Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) and B2 (TbrPDEB2) have gained interest as new treatments for human African trypanosomiasis. The recently reported alkynamide tetrahydrophthalazinones, which show submicromolar activities against TbrPDEB1 and anti-T. brucei activity, have been used as starting point for the discovery of new TbrPDEB1 inhibitors. Structure-based design indicated that the alkynamide-nitrogen atom can be readily decorated, leading to the discovery of 37, a potent TbrPDEB1 inhibitor with submicromolar activities against T. brucei parasites. Furthermore, 37 is more potent against TbrPDEB1 than hPDE4 and shows no cytotoxicity on human MRC-5 cells. The crystal structures of the catalytic domain of TbrPDEB1 co-crystalized with several different alkynamides show a bidentate interaction with key-residue Gln874, but no interaction with the parasite-specific P-pocket, despite being (uniquely) a more potent inhibitor for the parasite PDE. Incubation of blood stream form trypanosomes by 37 increases intracellular cAMP levels and results in the distortion of the cell cycle and cell death, validating phosphodiesterase inhibition as mode of action.

Item Type:	Article
DOI/Identification number:	10.1016/j.bmc.2019.06.026
Uncontrolled keywords:	Trypanosoma brucei, phosphodiesterase, B1Enzyme inhibitors, Neglected tropical disease, Human African trypanosomiasis, Structure-based drug discovery, Fluorescence microscopy
Divisions:	Divisions > Division of Natural Sciences > Biosciences
Depositing User:	David Brown
Date Deposited:	02 Oct 2019 16:09 UTC
Last Modified:	05 Nov 2024 12:41 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/76976 (The current URI for this page, for reference purposes)

University of Kent Author Information

Singh, Abhimanyu K..

Creator's ORCID:
CReDIT Contributor Roles:

Brown, David G..

Creator's ORCID:	https://orcid.org/0000-0003-4605-4779
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.